rs35400794
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_019109.5(ALG1):c.208+16_208+19dup variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.565 in 1,557,476 control chromosomes in the GnomAD database, including 250,491 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.55 ( 23328 hom., cov: 0)
Exomes 𝑓: 0.57 ( 227163 hom. )
Consequence
ALG1
NM_019109.5 intron
NM_019109.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.422
Genes affected
ALG1 (HGNC:18294): (ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase) The enzyme encoded by this gene catalyzes the first mannosylation step in the biosynthesis of lipid-linked oligosaccharides. This gene is mutated in congenital disorder of glycosylation type Ik. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 16-5072071-G-GGTCT is Benign according to our data. Variant chr16-5072071-G-GGTCT is described in ClinVar as [Benign]. Clinvar id is 95935.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.677 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG1 | NM_019109.5 | c.208+16_208+19dup | intron_variant | ENST00000262374.10 | NP_061982.3 | |||
ALG1 | XM_017023457.3 | c.208+16_208+19dup | intron_variant | XP_016878946.1 | ||||
ALG1 | XR_007064892.1 | n.215+16_215+19dup | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG1 | ENST00000262374.10 | c.208+16_208+19dup | intron_variant | 1 | NM_019109.5 | ENSP00000262374 | P1 |
Frequencies
GnomAD3 genomes AF: 0.553 AC: 83676AN: 151190Hom.: 23311 Cov.: 0
GnomAD3 genomes
AF:
AC:
83676
AN:
151190
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.558 AC: 87400AN: 156722Hom.: 25129 AF XY: 0.569 AC XY: 48038AN XY: 84424
GnomAD3 exomes
AF:
AC:
87400
AN:
156722
Hom.:
AF XY:
AC XY:
48038
AN XY:
84424
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.566 AC: 795844AN: 1406168Hom.: 227163 Cov.: 81 AF XY: 0.569 AC XY: 395389AN XY: 694410
GnomAD4 exome
AF:
AC:
795844
AN:
1406168
Hom.:
Cov.:
81
AF XY:
AC XY:
395389
AN XY:
694410
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.553 AC: 83730AN: 151308Hom.: 23328 Cov.: 0 AF XY: 0.558 AC XY: 41254AN XY: 73920
GnomAD4 genome
AF:
AC:
83730
AN:
151308
Hom.:
Cov.:
0
AF XY:
AC XY:
41254
AN XY:
73920
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
2345
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
ALG1-congenital disorder of glycosylation Benign:3
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 18, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 06, 2014 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 29, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at